drugset / Trial / NCT01700478

Study of the Use of Misoprostol to Decrease Bleeding During a Myomectomy

NCT01700478

Phase 4 Completed 45 enrolled University Hospital of the West Indies
NaSingle-groupDouble-blindPrevention

Summary

This study was done to determine if the use of a combination of preoperative rectal misoprostol 400µg used with intraoperative perivascular vasopressin is better than perivascular vasopressin used alone to decrease bleeding at myomectomy.

Timeline

Start
2005-02
Primary completion
2005-04
Completion
2005-04

Drugs

EvaluationDrugModalityDoseRoute
Subject Misoprostol Other / unclassified 400 ug Rectal
Background Vasopressin Peptide

Indications